首页> 外文会议>International Symposium on Supercritical Fluids >FORMULATION OF A CONTROLLED RELEASE CHEMOTHERAPEUTICAL SYSTEM BY THE ATOMIZED RAPID INJECTION SOLVENT EXTRACTION (ARISE) PROCESS
【24h】

FORMULATION OF A CONTROLLED RELEASE CHEMOTHERAPEUTICAL SYSTEM BY THE ATOMIZED RAPID INJECTION SOLVENT EXTRACTION (ARISE) PROCESS

机译:通过雾化快速注射溶剂萃取(出现)工艺制备控释化学乳液系统

获取原文

摘要

Dense gas anti-solvent precipitation processes have been studied extensively over the past two decades for the development of novel drug formulations. Their advantages include tunable fluid properties and a reduced use of toxic organic solvents. The Atomized Rapid Injection Solvent Extraction (ARISE) process is a recently developed dense gas anti-solvent process. The use of capillary nozzles, required by most dense gas anti-solvent processes, is eliminated and process operation is greatly simplified. In this study, the feasibility of using the ARISE process for the co-precipitation of the hydrophilic anticancer drug 5-fluorouracil with poly L-lactic acid was demonstrated. The effects of the processing conditions on particle morphology, encapsulation efficiency and drug loading were studied.
机译:过去二十年来广泛研究了致密的气体抗溶剂沉淀过程,以便开发新型药物制剂。它们的优点包括可调谐流体性质和减少毒性有机溶剂的使用。雾化的快速注射溶剂萃取(出现)工艺是最近显影的致密气体抗溶剂方法。通过大多数致密气体抗溶剂方法所需的使用毛细管喷嘴,并且大大简化了工艺操作。在该研究中,对使用聚L-乳酸的亲水性抗癌药物5-氟尿嘧啶共析出的使用过程的可行性。研究了处理条件对粒子形态,包封效率和药物载荷的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号